Pharmaceutical Industry Information Portal

HomeNews

News

GSK expands oncology product line by acquiring Sierra Oncology for $1.9 billion

GlaxoSmithKline plc and Sierra Oncology, Inc April 13th announced that the companies have entered into an agreement under which GSK will acquire Sierra Oncology,...

Engitix and Takeda expand collaboration in antifibrotic therapy

Engitix Ltd., a biotechnology company developing a portfolio of programmes in fibrosis and solid tumours using its proprietary human extracellular matrix (ECM) platform, April...

FDA partially suspends study of Curis’ lymphoma drug

Curis, Inc., a biotechnology company focused on the development of innovative therapeutics for the treatment of cancer, April 11th announced that the U.S. Food...

Oulu University Hospital has signed a strategic partnership with Philips to become “the smartest hospital in the world”

Royal Philips, a global leader in health technology, and Oulu University Hospital in Finland Apr 11th announced a strategic 10-year partnership agreement to support...

Veru’s new drug COVID-19 reduces deaths by 55% among hospitalized patients in an interim analysis of a phase 3 study

Veru Inc., an oncology biopharmaceutical company, April 11th announced positive efficacy and safety results of Phase 3 COVID-19 clinical trial evaluating oral sabizabulin versus...

Glenmark received approval to conduct clinical trials of its small molecule on patients with solid tumors and Hodgkin’s lymphoma

Glenmark Pharmaceuticals Limited, an innovation-driven, the global pharmaceutical company announced that its subsidiary Glenmark Specialty S.A. (Glenmark) received approval from the Indian drug regulator,...
spot_img

Expert Articles

spot_img